09:02 AM EDT, 08/20/2025 (MT Newswires) -- Ginkgo Bioworks Holdings ( DNA ) said Wednesday that its Datapoints offering has signed a collaboration with Inductive Bio and Tangible Scientific to develop artificial intelligence-driven lab-in-the-loop drug discovery.

Financial terms of the partnership were not disclosed.

The partnership will integrate Datapoints' rapid ADME profiling, Inductive's model-driven chemistry design platform, and Tangible's API-enabled compound management platform for experimental results in a single workstream, Ginkgo said.

These services are available now and customized for pharmaceutical and biotech teams, Ginkgo said.

Ginkgo's stock was up 4% in recent Wednesday premarket activity.